MARIA CECILLE DUNGO
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- THE DALLES, OR
- NPI
- 1235101874
- Received
- $6,968 in 94 records, 2019 to 2025
- As principal investigator
- $173,708 of research payments to others in 16 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 7 | $160 |
| 2024 | General payment | 1 | $24 |
| 2023 | General payment | 9 | $5,207 |
| 2022 | General payment | 6 | $126 |
| 2021 | General payment | 13 | $270 |
| 2020 | General payment | 4 | $66 |
| 2019 | General payment | 54 | $1,114 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Gilead Sciences, Inc. | 9 | $5,200 | 2021–2023 |
| Janssen Pharmaceuticals, Inc | 15 | $191 | 2019–2021 |
| Astellas Pharma US Inc | 7 | $191 | 2019–2024 |
| PFIZER INC. | 11 | $167 | 2019–2025 |
| Amgen Inc. | 7 | $165 | 2019–2021 |
| Lilly USA, LLC | 5 | $150 | 2019–2021 |
| Novartis Pharmaceuticals Corporation | 6 | $139 | 2019–2025 |
| Merck Sharp & Dohme LLC | 5 | $101 | 2019–2025 |
| COMSORT, Inc | 1 | $100 | 2019 |
| E.R. Squibb & Sons, L.L.C. | 5 | $81 | 2019–2025 |
| Incyte Corporation | 3 | $66 | 2019–2022 |
| Pharmacyclics LLC, an AbbVie Company | 3 | $63 | 2019 |
| GlaxoSmithKline, LLC. | 2 | $59 | 2025 |
| Celgene Corporation | 3 | $55 | 2019–2022 |
| SEAGEN INC. | 2 | $48 | 2021–2022 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 | 2019–2021 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 | 2019–2021 |
| Myovant Sciences Inc. | 1 | $27 | 2021 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 | 2019 |
| Janssen Biotech, Inc. | 2 | $22 | 2019–2023 |
| Sirtex Medical Inc | 1 | $17 | 2022 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $11 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 2 | $4,370 |
| Food and Beverage | 85 | $1,746 |
| Travel and Lodging | 3 | $718 |
| Education | 4 | $133 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | GlaxoSmithKline, LLC. | $32 | Food and Beverage | In-kind items and services | BLENREP Biological, ONCOLOGY | 2025 | |
| 2025-11-03 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-10-28 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-07 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-09-24 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-09-09 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-09-02 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2024-05-06 | Astellas Pharma US Inc | $24 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2024 | |
| 2023-05-03 | Gilead Sciences, Inc. | $4,270 | Consulting Fee | Cash or cash equivalent | Trodelvy Drug, ONC | 2023 | |
| 2023-04-22 | Gilead Sciences, Inc. | $50 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-04-22 | Gilead Sciences, Inc. | $50 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-04-22 | Gilead Sciences, Inc. | $49 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-04-22 | Gilead Sciences, Inc. | $49 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-04-21 | Gilead Sciences, Inc. | $269 | Travel and Lodging | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-04-21 | Gilead Sciences, Inc. | $255 | Travel and Lodging | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-03-28 | Gilead Sciences, Inc. | $193 | Travel and Lodging | In-kind items and services | Trodelvy Drug, ONC | 2023 | |
| 2023-01-24 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, Oncology | 2023 | |
| 2022-12-21 | Sirtex Medical Inc | $17 | Food and Beverage | Cash or cash equivalent | SIR-Spheres Microspheres Device, Interventional Oncology | 2022 | |
| 2022-08-26 | Celgene Corporation | $18 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2022 | |
| 2022-05-10 | SEAGEN INC. | $26 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2022 | |
| 2022-04-14 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | Pomalyst Drug, Hematology | 2022 | |
| 2022-03-31 | Incyte Corporation | $24 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2022 | |
| 2022-03-08 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2022 | |
| 2021-12-07 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | TASIGNA Drug, HEMATOLOGY | 2021 | |
| 2021-11-11 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2021 | |
| 2021-11-03 | Myovant Sciences Inc. | $27 | Food and Beverage | In-kind items and services | ORGOVYX Drug, HORMONE THERAPY | 2021 | |
| 2021-10-06 | Janssen Pharmaceuticals, Inc | $27 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2021 | |
| 2021-08-31 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | PROMACTA Drug, ONCOLOGY | 2021 | |
| 2021-08-11 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2021 | |
| 2021-08-10 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2021 | |
| 2021-08-03 | Alexion Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-06-15 | SEAGEN INC. | $22 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2021 | |
| 2021-06-08 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2021 | |
| 2021-06-03 | Astellas Pharma US Inc | $20 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2021 | |
| 2021-06-01 | Gilead Sciences, Inc. | $11 | Education | In-kind items and services | 2021 | ||
| 2021-05-12 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | 2021 | ||
| 2020-12-16 | PFIZER INC. | $13 | Education | In-kind items and services | INLYTA Drug, ONCOLOGY | 2020 | |
| 2020-07-16 | Incyte Corporation | $23 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2020 | |
| 2020-06-18 | Astellas Pharma US Inc | $13 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2020 | |
| 2020-02-27 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2020 | |
| 2019-12-19 | Incyte Corporation | $18 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2019 | |
| 2019-12-06 | Lilly USA, LLC | $93 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2019 | |
| 2019-12-06 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2019 | |
| 2019-12-06 | Lilly USA, LLC | $8 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2019 | |
| 2019-12-05 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2019 | |
| 2019-11-26 | Astellas Pharma US Inc | $17 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-25 | Astellas Pharma US Inc | $2 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-11-21 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-11-21 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | ALIMTA Drug, Oncology | 2019 | |
| 2019-11-11 | PFIZER INC. | $13 | Education | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2019 | |
| 2019-11-05 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-11-05 | Janssen Biotech, Inc. | $3 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2019 | |
| 2019-10-11 | COMSORT, Inc | $100 | Consulting Fee | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2019 | |
| 2019-10-09 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2019 | |
| 2019-10-07 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-10-03 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-09-24 | Astellas Pharma US Inc | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2019 | |
| 2019-09-17 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | BAVENCIO Drug, ONCOLOGY | 2019 | |
| 2019-09-17 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | BAVENCIO Drug, ONCOLOGY | 2019 | |
| 2019-09-05 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | MVASI Biological, Oncology | 2019 | |
| 2019-08-27 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | MVASI Biological, Oncology | 2019 | |
| 2019-08-15 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-08-01 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-07-18 | Janssen Pharmaceuticals, Inc | $11 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-07-17 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | MEKINIST Drug, ONCOLOGY | 2019 | |
| 2019-07-03 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-06-13 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | Neulasta Biological, Oncology | 2019 | |
| 2019-06-12 | Amgen Inc. | $33 | Food and Beverage | In-kind items and services | Prolia Biological, Bone Health | 2019 | |
| 2019-06-04 | Janssen Pharmaceuticals, Inc | $7 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-05-22 | Janssen Pharmaceuticals, Inc | $34 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-04-16 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | Prolia Biological, Bone Health | 2019 | |
| 2019-04-11 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2019 | |
| 2019-04-09 | Pharmacyclics LLC, an AbbVie Company | $21 | Food and Beverage | In-kind items and services | Imbruvica Drug, Oncology | 2019 | |
| 2019-04-08 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | EMPLICITI Biological, Oncology | 2019 | |
| 2019-04-03 | Janssen Pharmaceuticals, Inc | $4 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-04-02 | Bayer Healthcare Pharmaceuticals Inc. | $11 | Food and Beverage | In-kind items and services | Aliqopa Drug, Oncology | 2019 | |
| 2019-04-01 | Astellas Pharma US Inc | $95 | Education | In-kind items and services | 2019 | ||
| 2019-03-26 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | Prolia Biological, Bone Health | 2019 | |
| 2019-03-20 | Janssen Pharmaceuticals, Inc | $8 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-03-18 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2019 | |
| 2019-03-14 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | PROMACTA Drug, ONCOLOGY | 2019 | |
| 2019-03-07 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | PROMACTA Drug, ONCOLOGY | 2019 | |
| 2019-03-06 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-02-21 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | IMFINZI Drug, Cardiovascular and Metabolism | 2019 | |
| 2019-02-14 | Regeneron Healthcare Solutions, Inc. | $22 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2019 | |
| 2019-02-14 | Pharmacyclics LLC, an AbbVie Company | $21 | Food and Beverage | In-kind items and services | Imbruvica Drug, Oncology | 2019 | |
| 2019-02-14 | Merck Sharp & Dohme LLC | $13 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2019 | |
| 2019-02-12 | Celgene Corporation | $21 | Food and Beverage | In-kind items and services | Abraxane Drug, Oncology | 2019 | |
| 2019-02-08 | Janssen Pharmaceuticals, Inc | $6 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-02-05 | Merck Sharp & Dohme LLC | $26 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-01-31 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-01-31 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-01-24 | Alexion Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | ULTOMIRIS Drug, Immunology | 2019 | |
| 2019-01-09 | Pharmacyclics LLC, an AbbVie Company | $20 | Food and Beverage | In-kind items and services | Imbruvica Drug, Oncology | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-01-23 | GE HEALTHCARE | Memorial Health Services | $690 | An open-Label multicenter Phase 2 dose-evaluation study of Altropane (123I) Injection or striatal dopamine transporter v | 2025 |
| 2025-01-23 | GE HEALTHCARE | Memorial Health Services | $2,415 | An open-Label multicenter Phase 2 dose-evaluation study of Altropane (123I) Injection or striatal dopamine transporter v | 2025 |
| 2025-01-23 | GE HEALTHCARE | Memorial Health Services | $2,760 | An open-Label multicenter Phase 2 dose-evaluation study of Altropane (123I) Injection or striatal dopamine transporter v | 2025 |
| 2025-01-23 | GE HEALTHCARE | Memorial Health Services | $6,700 | An open-Label multicenter Phase 2 dose-evaluation study of Altropane (123I) Injection or striatal dopamine transporter v | 2025 |
| 2024-06-07 | AstraZeneca UK Limited | Memorial Health Services | $8,970 | A Phase II, Multicentre, Open-Label Study to Assess the Efficacy and Safety of Olaparib Monotherapy and Olaparib Plus Du | 2024 |
| 2024-01-24 | GE HEALTHCARE | Memorial Health Services | $690 | Impact of Cerianna PET/CT on Treatment Decisions in Metastatic Breast Cancer Patients | 2024 |
| 2024-01-10 | GE HEALTHCARE | Memorial Health Services | $25,995 | Impact of Cerianna PET/CT on Treatment Decisions in Metastatic Breast Cancer Patients | 2024 |
| 2023-12-20 | GE HEALTHCARE | Memorial Health Services | $2,760 | PET molecular imaging tracers for oncology indications and its impact on clinical management | 2023 |
| 2023-12-20 | GE HEALTHCARE | Memorial Health Services | $52 | PET molecular imaging tracers for oncology indications and its impact on clinical management | 2023 |
| 2023-05-25 | AstraZeneca UK Limited | Memorial Health Services | $40,190 | A Phase II, Multicentre, Open-Label Study to Assess the Efficacy and Safety of Olaparib Monotherapy and Olaparib Plus Du | 2023 |
| 2023-01-16 | GE HEALTHCARE | Memorial Health Services | $18,028 | PET molecular imaging tracers for oncology indications and its impact on clinical management | 2023 |
| 2023-01-16 | GE HEALTHCARE | Memorial Health Services | $18,028 | PET molecular imaging tracers for oncology indications and its impact on clinical management | 2023 |
| 2023-01-16 | GE HEALTHCARE | Memorial Health Services | $18,028 | PET molecular imaging tracers for oncology indications and its impact on clinical management | 2023 |
| 2020-03-27 | PFIZER INC. | Memorial Health Services | $3,915 | PHASE 2 STUDY IN PATIENTS WITH NEOADJUVANT BREAST CANCER | 2020 |
| 2019-07-09 | PFIZER INC. | Memorial Health Services | $7,700 | PHASE 2 STUDY IN PATIENTS WITH NEOADJUVANT BREAST CANCER | 2019 |
| 2019-05-08 | PFIZER INC. | Memorial Health Services | $16,785 | PHASE 2 STUDY IN PATIENTS WITH NEOADJUVANT BREAST CANCER | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In The Dalles, OR, county Wasco County, OR, state Oregon; placed by its city name.
| Measure | Place (city or town) The Dalles, OR | County Wasco County, OR | State Oregon |
|---|---|---|---|
| Population B01003 | 15,917 | 26,552 | 4,254,293 |
| Population, 2020 census P1 | 16,010 | 26,670 | 4,237,256 |
| Median age B01002 | 38.5 | 41.0 | 40.4 |
| Under 18 B01001 | 22.5% | 21.4% | 19.9% |
| 65 and over B01001 | 20.1% | 21.4% | 19.1% |
| Households B11001 | 6,525 | 10,563 | 1,718,422 |
| Foreign born B05002 | 9.1% | 9.9% | 9.8% |
| Median household income B19013 | $62,614 | $64,175 | $83,011 |
| Median family income B19113 | $89,080 | $87,031 | $102,281 |
| Per capita income B19301 | $40,289 | $38,408 | $45,612 |
| Poverty rate B17001 | 11.0% | 11.6% | 11.9% |
| Unemployment rate B23025 | 7.7% | 7.7% | 5.4% |
| Civilian labor force B23025 | 7,826 | 12,892 | 2,183,462 |
| Mean commute (minutes) B08013 | 16.5 | 18.9 | 23.0 |
| Bachelor's degree or higher B15003 | 22.7% | 22.4% | 36.8% |
| Housing units B25001 | 6,964 | 12,198 | 1,857,992 |
| Owner-occupied B25003 | 63.2% | 67.5% | 63.3% |
| Renters B25003 | 36.8% | 32.5% | 36.7% |
| Median home value B25077 | $360,800 | $367,400 | $477,600 |
| Median gross rent B25064 | $993 | $1,008 | $1,525 |
| White, not Hispanic B03002 | 70.7% | 70.8% | 71.4% |
| Black B03002 | 0.5% | 0.4% | 1.8% |
| Hispanic or Latino B03002 | 21.4% | 20.6% | 14.7% |
| Asian B03002 | 0.5% | 0.7% | 4.4% |
| American Indian and Alaska Native B03002 | 0.7% | 1.8% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in The Dalles, OR.
Comments